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ABSTRACT 
Coagulopathy, a condition in which blood coagulation is impaired, can be 
inherited or result from a variety of conditions including severe trauma, illness or 
surgery. Perioperative monitoring of a patient’s coagulation status is important to identify 
coagulopathic patients. Thromboelastography or TEG remains the gold standard for 
whole blood coagulation monitoring. However, TEG suffers from certain well-
documented drawbacks such as contact containment and manipulation of the blood 
sample, large and uncontrolled strain, and the inability to distinguish the contribution of 
elasticity and viscosity during blood coagulation. We developed a non-contact blood 
rheometer which uses a single drop of blood to measure its viscoelastic properties. Small 
sample size (typically 5-15 µL), low shear strain (linear viscoelasticity), and non-contact 
manipulation and containment of samples make this technique unique for real-time 
monitoring of blood coagulation. 
In the first part of this work, we addressed the development of the technique, 
benchmarking the results against known material properties standards. We observed large 
amplitude oscillations of the levitated drop results in multiple resonance modes and 




required to satisfy the Lamb theoretical expressions for drop frequency and damping. In 
the second part, we applied our technique to study sickle-cell disease. Our technique 
showed that the shape oscillation of blood drops was able to assess an abnormally 
increased viscosity in sickle cell patients when compared with normal controls over a 
range of hematocrit. Furthermore, the technique was sensitive enough to detect viscosity 
changes induced by hydroxyurea treatment. The third part of this work focused on blood 
coagulation monitoring. The technique showed sensitivity to coagulation parameters, 
such as platelet count, calcium ion concentration, and hematocrit. A comparison of the 
results with TEG showed coagulation started sooner in the levitation technique, but with 
a lower rate and lower maximum stiffness. Thus, the technique developed can be used as 
a monitoring tool to assess blood mechanical properties sensitively enough to be of use in 
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CHAPTER ONE: Introduction and Background 
1.1. Acoustic Levitation 
 
Levitation techniques are used for the non-contact processing of samples in 
material research. There are six levitation techniques extensively used: Magnetic, 
Electrostatic, Electrodynamic, Aerodynamic, Optical, and Acoustic. Acoustic levitation is 
unique in that the acoustic force used to position and manipulate samples is qualitatively 
material independent. Conductors or insulators, fluids or solids can be acoustically 
levitated. The primary disadvantages of acoustic levitation are acoustic streaming and the 
deformation of fluid samples[2].  
Figure 1.1 illustrates the levitation of water-glycerol drops in an ultrasonic planar 
standing wave field maintained by a piezoelectric transducer plus horn (bottom) and a 
concentric reflector. Also shown is the pressure profile of the standing wave. The 
pressure field around the sample produces an axial acoustic force that counteracts the 
gravity force. In microgravity, a particle would be positioned exactly in the pressure 
node, i.e. a point of zero acoustic pressure. On earth, a light particle may also levitate 







Figure 1.1. (Left) Illustration of the instantaneous temporal peak acoustic pressure in an 
ultrasonic standing wave in air (Right) Levitated drops of water-glycerol solution in a 30 kHz 
acoustic field 
 
The levitation force comes from the acoustic radiation pressure, which originates 
from the presence of the incident and scattered acoustic waves from the particle. When 
acoustic radiation pressure acts on the surface of a small object, it imposes a net force on 
the object called the acoustic radiation force. Acoustic radiation pressure was first 
observed by Kundt [3] in 1866 and studied by Lord Rayleigh in the early 1900’s [4], [5].  
To calculate the acoustic radiation force, we start from the acoustic potential 
energy of a particle of radius R in an acoustic field derived by Barmatz and Collas based 
on Gar’kov method[6]: 
  (1.1) 
Where  ,  and                ,               . 
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ρ and c are density and sound velocity, respectively (H and L represent host and liquid). 
R is the drop spherical equivalent radius, P is the rms acoustic pressure, and u is the rms 
acoustic velocity.  Except for the sound speed and density contrasts f1 and f2 above, it is 
clear that the un-subscripted acoustic pressure P, velocity u, density r and sound speed c 
in equations 1.1 – 1.14 are those for the host medium (air in this thesis), we will drop the 
subscripts. 
If we write R in terms of drop volume ,   
   (1.2) 
Acoustic radiation force is the gradient of potential energy, as 
  (1.3) 
If we define Ф as a velocity potential function, we have 
  (1.4) 
  (1.5) 
Substituting Eq. (1.5) in Eq. (1.4) 
  (1.6) 
Assuming that u varies sinusoidally with frequency ω, 
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  (1.8) 
Substituting Eq. (1.8) in Eq. (1.3) 
                                                              (1.9) 
Using the wave number  in Eq. (1.9) 
                                                                      (1.10) 
Defining pressure as 
  (1.11) 
The time average and gradient for inclusion in Eq. (1.10) will be  
  (1.12) 
  (1.13) 
By substituting Eq. (1.12) and Eq. (1.13) in Eq. (1.10), the total body force (  ) on a 
liquid sample in an acoustic field can be obtained as. 
                                                                                                              (1.14) 
 
 ,   ,  , and z are sample volume, sound pressure amplitude, sound wave 
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An acoustic levitator is composed of two main parts: transducer and reflector. The 
transducer consists of an aluminum horn connected to two piezoelectric disks which 
vibrates in a frequency around 30 KHz. In order to have the entire system as a half-
wavelength resonator, the horn length is adjusted to 8.6 cm (sound speed in aluminum is 
5150 m/s). So the system is vibrating with standing waves at its resonant frequency (~ 30 
KHz). The generated sound waves from the transducer reflect back from the reflector. To 
have a standing wave between the transducer and reflector, the reflector should be placed 
an integer number of half wavelength above the transducer. In our levitator, the distance 
of ~11 cm will provide one full wavelength with two pressure nodes (Figure 1.1).  
Acoustic levitation has a relatively long history of applications for both studies of 
drop dynamics [7] and the use of drop dynamics as a probe for surface properties [8], [9]. 
The details of studies on using acoustic levitation to infer material properties will be 
discussed in chapter 2. In recent years, acoustic levitation has been rediscovered as a 
means for acoustophoretic contactless transport and mixing [10]–[15], scrubbing and 
manipulation of particles [16]–[21], crystallography [22], and micro- [23] and 
biophysical measurements [24]. When coupled with shape oscillations of the levitated 
drop, it can be used to infer thermophysical properties such as surface tension and 
viscosity [25]–[35]. The importance of levitation methods becomes clear when the 
properties of molten or reactive materials are desired. For instance, molten silicon is 
highly reactive with most crucibles, resulting in melt contamination and subsequent 




1.2. Blood Rheology 
The study of hemorheology has been of great interest in the fields of biomedical 
engineering and medical research for many years. [36]–[39]. Hemorheological properties 
of blood include whole blood viscosity, plasma viscosity, hematocrit, RBC deformability 
and aggregation, and fibrinogen concentration in plasma. Although a number of 
parameters such as pressure, vessel diameter, whole blood viscosity, compliance of 
vessels, peripheral vascular resistance are well-known physiological parameters that 
affect the blood flow, the whole blood viscosity is an important key physiological 
parameter.  
Studying blood viscosity in patients with coronary arterial disease such as 
ischemic heart disease and myocardial infarction showed that the change in viscosity of 
whole blood might be associated with coronary arterial diseases [40]–[44]. In addition, 
blood viscosity has been reported significantly higher in patients with peripheral arterial 
disease than that in healthy controls [45]–[47]. Some other studies showed elevated blood 
viscosity, plasma viscosity, RBCs and platelet aggregation and RBC rigidity in patients 
with stroke [48]–[51].  
It was also reported that both whole blood viscosity and plasma viscosity were 
significantly higher in patients with essential hypertension than in healthy people [52]–
[57]. In diabetics, whole blood viscosity, plasma viscosity, and hematocrit were elevated, 
whereas RBC deformability was decreased [58]–[62]. 
Others reported a correlation between whole blood viscosity and smoking, age, 




addition, it was reported that male blood possessed higher blood viscosity, RBC 
aggregability, and RBC rigidity than premenopausal female blood, which may be 
attributed to monthly blood-loss [66].  
Viscosity of Newtonian Fluids is independent of shear rate. So if shear stress is 
plotted against shear rate at a given temperature, the plot shows a straight line with a 
constant slope (see Figure 1.2). This slope is called the viscosity of the fluid. Low 
molecular fluids, all gases, and common liquids such as water and glycerin are 
Newtonian.  
Eq. (1.15) shows  the constitutive equation for Newtonian fluid [68], [69]: 
   (1.15) 
where μ is the Newtonian viscosity and  is the shear rate or the rate of strain. 
 
(a)                                                       (b) 
Figure 1.2. Newtonian fluid (a) Shear stress vs. Shear rate. (b) Viscosity vs. Shear rate. 
 
Any fluids that do not obey the Newtonian relationship between shear stress and 
shear rate are non-Newtonian. The subject of rheology is devoted to the study of the 






suspensions of fine particles are usually non-Newtonian. Also, many important fluids, 
such as blood and paint show non-Newtonian viscosity. 
For non-Newtonian fluids, the slope of the shear stress versus shear rate curve is 
not constant. When the viscosity of a fluid decreases with increasing shear rate, the fluid 
is called shear-thinning. In the opposite case where the viscosity increases as the fluid is 
subjected to a high shear rate, the fluid is called shear-thickening.  
Blood behaves like a non-Newtonian fluid whose viscosity changes with shear 
rate (Figure 1.3). The non-Newtonian characteristics of blood come from the presence of 
various cells in the blood (typically making up 45% of the blood’s volume), which make 
blood a suspension of particles [70], [71].  
 
Figure 1.3. Whole blood viscosity vs. shear rate (Shear thinning characteristic)  
 
Some researchers have studied blood viscosity in order to formulate a theory to 
determine blood viscosity [71]–[73]. Four main determinants of whole blood viscosity 
have been identified as: (1) plasma viscosity, (2) hematocrit, (3) RBC deformability and 
aggregation, and (4) temperature. The first three factors are parameters of physiologic 




the second and third factors (hematocrit and RBC aggregations) mainly contribute to the 
non-Newtonian characteristics of shear-thinning viscosity. Here, we discuss each of these 
main factors: 
 
1.2.1. Plasma  
If we remove all cellular elements from blood, what we get is called plasma. 
Several experiments showed that plasma viscosity doesn’t change with shear rate over a 
wide range of shear rate (i.e., from 0.1 to 1200 s-1), so it has been well established that 
plasma is a Newtonian fluid [1]. Figure 1.4 illustrates the difference between plasma and 
whole blood [59], [72]. Since blood is a suspension of cells in plasma, the plasma 
viscosity affects whole blood viscosity, particularly at high shear rates. 
 







The volume percentage of red blood cells in whole blood is called hematocrit 
(Hct). Because plasma shows a Newtonian behavior [70], the non-Newtonian features of 
human blood come from suspended cells in blood. The rheological properties of 
suspensions correlate with the concentrations of suspended particles. Since, the most 
important suspended particles in blood are the red blood cells, hematocrit is a critical 
determinant of whole blood viscosity[70], [74]–[77]. Studies showed that the viscosity of 
whole blood varies directly with hematocrit. Meaning, the higher the hematocrit, the 
greater the value of whole blood viscosity[71]–[73], [78]. 
 
1.2.3. RBC Deformability 
RBCs are bio-concave disks with diameter of 8 µm and thickness of 2 µm [79]. 
Normal RBCs can undergo large amount of deformability under shear stress. 
Deformability is defined as the degree of deformability of RBC under a given shear 
force. RBCs deformability plays the critical role as they flow through capillaries with 
diameters smaller than their size. If RBCs deformability decreases even slightly, they are 
not able to enter capillaries, resulting in disease states such as sickle cell disease which 
will be discussed in chapter 3.  
Shin et al. [79] studied the effect of RBCs deformability on blood viscosity. They 
hardened RBCs by exposing them to a solution of hydrogen peroxide with a 
concentration level (2 mM) for 30 min. The suspension of hardened RBCs showed higher 




sickle cell blood is more viscous than normal blood . 
1.2.4. RBC Aggregation  
When a number of red cells cluster together as in the flow of a low shear rate, 
they aggregate together. Accordingly, human RBCs have the ability to form aggregates 
known as rouleaux. Figure 1.5. illustrates the relationship between blood viscosity and 
rouleaux formation. Rouleaux formation of healthy red cells increases at decreasing shear 
rates. As red cells form rouleaux, they will tumble while flowing in vessels. The tumbling 
disturbs the flow locally and requires the consumption of energy, thus increasing the 
apparent blood viscosity at low shear [70]. As shear rate increases, blood aggregates tend 
to be broken up, resulting in a drop in effective blood viscosity (see Fig. 1.5). This 
provides a partial explanation for the shear thinning behavior seen above in Fig. 1.3. 
 
Figure 1.5. Elevated blood viscosity at low shear rates indicates RBC aggregation (rouleaux 
formation). Blood viscosity decreases with increasing shear rates as RBC aggregations breaks up 






Like other fluids, viscosity of whole blood and plasma increases by decreasing 
temperature [70], [71]. In blood, reduced RBC deformability and increased plasma 
viscosity particularly elevate whole blood viscosity at low temperatures [80]. So, precise 
control of the sample temperature is necessary to compare measurements of viscosity 
accurately in vitro. It is a standard in hemorheologic studies to perform blood viscosity 
measurements at body temperature of 37 ℃.  
  
 
1.3. Sickle Cell Disease 
Sickle cell disease is one of the most commonly inherited diseases worldwide 
with over 250,000 new births each year, and some 70,000–100,000 affected patients in 
North America [81]. In SCD, a point mutation occurs in the gene responsible for the 
production of the β-chain in hemoglobin (Hb), the main protein in red blood cells that is 
responsible for oxygen transport [82]. This mutation changes the hydrophilic glutamic 
acid to a hydrophobic valine amino acid residue in the β-globin chain gene, giving rise to 
hemoglobin S (HbS), a variant form of Hb. Under certain physiological conditions (e.g., 
deoxygenation) the sickle hemoglobin (HbS) can polymerize into long strands, resulting 
in stiffened and often sickle-shaped red blood cells [83]. Exposing cells to a normal 
oxygen environment (normoxic) melts the fibers, but permanent and irreversible damage 
results from repeated exposure to alternating low-oxygen and normoxic 
environments[84]–[87] and this may be a consequence of abnormal entry of Ca into the 




This irreversible membrane damage leads to stiffer sickle RBCs, which are unable 
to unsickle after re-exposure to normoxic environment (irreversibly sickled cells) [92], 
[93]. These RBCs may adversely affect blood flow [94] and contribute to vessel 
occlusion, poor oxygen transport, and hemolysis [95], [96]. Sickle cell patients 
sometimes experience painful vaso-occlusive event (often referred to as pain “crisis”). 
The crisis which is the main characteristics of sickle cell disease happens suddenly 
without specific warning symptoms. The pain typically presents in the chest, back, or 
extremities and requires hydration, analgesia, and frequent treatment, including 
hospitalization. Other acute vaso-occlusive events include splenic sequestration, acute 
chest syndrome, and stroke [97]. Moreover, symptoms such as priapism, leg ulcers, and 
possibly pulmonary hypertension, are known the complex pathophysiology of SCD.  
Usually organ damage begins at young ages in sickle cell patients and worsens 
over time ultimately affecting the brain, kidney, lung, spleen, bones, and eyes, which 
could lead to mortality [98]. SCD is a chronic disease which can cause hemolytic anemia 
and frequent vaso-occlusive events with subsequent organ damage later in patients’ lives. 
So, early treatment in young patients who have not yet developed serious or irreversible 
organ damage is a top priority of doctors.  
Hydroxyurea (HU) has been until very recently the only FDA-approved drug for 
treating SCD [99]. Through multiple mechanisms of action, Hydroxyurea has many 
characteristics of an ideal drug for sickle cell patients. Over the past 25 years, safety and 
efficacy of HU for patients with SCD in affected adults, then adolescents and children, 




Studies show that HU-treatment increases fetal hemoglobin (HbF) production in 
RBCs [100]–[103]which inhibits the polymerization of HbS. Among several agents 
which can induce fetal hemoglobin production in SCD patients, hydroxyurea has been 
used to treat SCD patients because of its ease of oral administration, modest toxicity 
profile, effect on hemolysis, and proven clinical efficacy for preventing acute vaso-
occlusive events.  
 
1.4. Blood Coagulation 
The normal coagulation process, which is called hemostasis, is the body’s defense 
mechanism to prevent severe blood loss due to uncontrolled bleeding. Blood coagulation 
involves multiple plasma proteins (coagulation factors), platelets, and red blood cells that 
work together through a cascade of biochemical processes to stop bleeding following 
injury [104].   
Coagulopathy, a condition in which blood coagulation is impaired, can result 
from a variety of conditions including severe trauma, illness or surgery [105], [106], and 
can cause life-threatening bleeding or thrombotic disorders. For instance, deficient blood 
coagulation can lead to ‘hypo-coagulable’ states resulting in prolonged or uncontrolled 
bleeding, which may cause severe anemia, shock and multiple organ failure [107], [108]. 
In other cases, coagulation defects may show their effects as ‘hyper-coagulable’ states, 
causing increased clotting that can result in potentially fatal complications such as deep 
vein thrombosis and pulmonary embolism[109]. Coagulopathies may also be inherited 




platelet function, or may be acquired due to chronic illness or the use of certain anti-
inflammatory or anti-coagulant agents[105], [111]. 
Monitoring a patient’s coagulation status during surgery, trauma care and disease 
management is important to keep the balance between bleeding and thrombosis. This will 
also help doctors identify coagulopathic patients to treat coagulation defects and save 
their lives. By monitoring changes in the viscoelastic properties of clotting blood the 
coagulation status can be obtained. A key mechanism in the coagulation process involves 
the conversion of fibrinogen into insoluble strands of fibrin through catalytic action of the 
protease thrombin. This is followed by subsequent fibrin cross-linking and platelet 
adhesion leading to the formation of a platelet-fibrin mesh which increases the 
viscoelastic properties of clotting blood [112]. As a result, by measuring changes in the 
viscoelastic properties of blood, clotting time can be assessed, which is an important 
indicator of the patient’s coagulation status. 
Several ex vivo mechanical tests of clot stiffness have successfully transitioned 
into the clinic, most notably the thromboelastogram (TEG) and rotational 
thromboelastometry (ROTEM) [113]–[115]. There are a number of new technologies that 
are being developed based on diverse approaches to look at the dynamics of blood 
clotting both in vivo and ex vivo. Dynamic light scattering analysis has been used to 
measure in vivo the clotting of blood by comparing motion of RBCs in flow or in stasis 
[116]and laser speckle rheology has been used to correlate changes in light scattering 
speckle intensity with viscoelastic property changes ex vivo[117]. A new approach that 




sample is RheoSpectris[118]. Ultrasound imaging has been used for detection of material 
strains in tissue following external application of force[119], [120]. In addition there are 
multiple microelectromechanical systems (MEMS) technologies that incorporate micro-
cantilever or piezoelectric approaches to measure the changes in material properties of 
blood ex-vivo [121], [122]. 
However, all of these techniques available for the measurement of rheological 
properties of biological fluids (blood, living cells, soft tissues, and bio-engineered 
materials) require contact of the sample with the walls of the measuring device. Many 
biological fluids, however, are very sensitive to the external environment because they 
consist of cross-linked networks of reactive proteins or polymers. These networks may 
reorganize in response to mechanical stimuli induced by the interaction of a biological 
sample with the rheometer walls, thereby changing the rheological properties of the 
sample. Animal cells, such as leukocytes, for example, may significantly change their 
deformability and shape (i.e., they are activated), when they come in contact with the 
walls of blood vessels or interact with adhesive surfaces. The transduction of biochemical 
signals from the surface to the nucleus of the leukocyte initiates a cascade of events that 
result in cytoskeleton remodeling[123]. Similar processes may occur in tissues in contact 
with engineered materials[123], [124]. Even in the case of nonreactive media, the 
accuracy of rheological measurements is reduced because of the wall slip effects[125], 
[126]. All these observations indicate that the accurate rheological characterization of 
biological fluids can be more readily achieved by non-contact means. We should add here 




is at high risk for bacterial contamination, which may lead to uncontrollable changes in 
the sample.  
In this thesis, we develop a method for non-contact rheological measurement of 
biological fluids in which the sample will be levitated in a host fluid by the acoustic 
radiation force. In this technique, a sample will be levitated in an aqueous medium or air 
by the radiation force from a standing acoustic wave field. The field will be perturbed by 
amplitude modulating the field, leading to the oscillatory shape deformation of the 
sample. Analytical models will then be applied to the experimental data of the sample 




CHAPTER TWO: The Effect of Finite Amplitude Oscillation of Levitated Drop on 
Inferred Material Properties 
Chapter Two is Reproduced from “Finite amplitude effects on drop levitation for 
material properties measurement” , 121(17), 174502 , Vahideh Ansari Hosseinzadeh and 
R.Glynn Holt, Journal of Applied Physics (2017), with permission from AIP Publishing 
[127]. 
 
2.1. Acoustic Levitation as a Non-Contact Technique to Infer Material Properties  
 
The acoustic levitation technique used to measure the surface tension and 
viscosity relies on the excitation of drop shape oscillations [8], [25]–[27]. In this 
technique, a levitated drop is typically excited in the quadrupole (n = 2) mode of 
oscillation, where the expected natural frequency and the damping ratio for axisymmetric 
shape oscillations of mode n are   often referred to as the Lamb 
frequency and  for a Newtonian liquid (see Appendix C for the 
derivation)[128]. σ, ρ, R, and µ are surface tension, density, drop radius, and viscosity, 
respectively. There are two commonly employed diagnostic techniques used to monitor 
the drop shape variation during the oscillation: imaging (often high-speed) [33]and laser 
scattering[34]. 
Several practical problems arise when applying the drop shape oscillation 
technique to infer material properties. Various researchers have reported a multiplicity of 
peaks in the frequency response function (FRF)[8], anomalously lower resonance 
frequency [129] and consequently lower inferred surface tension, non-axisymmetric drop 























higher inferred surface tension[131], and apparent drop size dependence of inferred 
viscosity[34], [132]. Many different factors have been proposed to explain these 
phenomena: internal flow-excited oscillations[133], nonlinearity of the response[130], 
[134], non-spherical equilibrium shape of the drop[8], [135]–[137], the imperfect 
symmetry of the levitation devices[8], possible contamination of the drop from the 
deployment system[8], [30], [138], a positioning field effect[8], [25], [27], [34], [129], 
[132], and translational or rotational movement of the sample during the oscillation[8], 
[139], [140]. 
Some particular solutions have been proposed by researchers; for example, to 
avoid the size-dependent inferred viscosity, Ishikawa et al. suggested selecting the 
sample size and the position control parameters to avoid the control frequency overlap 
with the sample oscillation frequency in electrostatic levitators[29], [34], [132]. Egry et 
al. presented frequency-domain analysis methods to eliminate the effect of translational 
and rotational movement of drops[139]. Defining a weighted average of the multiple 
peaks in the FRF to yield a “true” resonance frequency was proposed by Suryanarayana 
and Bayazitoglu[137]. Soda et al. [131]derived an empirical amplitude correction factor 
to account for large amplitude oscillation effects on surface tension measurements. 
Although all these proposed solutions worked in the particular instance, none of them can 
claim to be a general solution to the problems attendant on finite-amplitude drop 
oscillations. 
In contrast, Becker et al. [134]concluded that if the oscillation amplitude of the 




be negligible, and thus presumably, the problems alluded to in the previous paragraph 
will also be eliminated. Because of this additional requirement, many investigators found 
it necessary to leave Earth to obtain accurate measurements, taking advantage of various 
reduced gravity environments to reduce the amplitude of the levitation field necessary to 
stably position the drop sample[8], [25], [28], [33], [133], [141]. Although most 
researchers have tried to avoid mode frequency shifts, recently, Jamin et al. [129]sought 
to take advantage of shape mode frequency shifting by purposely inducing the shift, as a 
means to avoid some problematic frequency bands in practical situations, likening the 
field effect to an effective “negative surface tension”. 
Here, we demonstrate that the primary cause of almost all the problems reported 
in the literature is the excitation and use of finite amplitude oscillations for material 
property inference. By first reproducing and then eliminating the problems of multiple or 
shifted peaks and apparent size dependence, we show that the employment of very small 
oscillation amplitudes and a suitably sensitive diagnostic technique allows the correct 
inference of surface tension and viscosity over a wide range of these parameters. 
 
2.2. Apparatus and Methods 
Our experiments are performed with a single-axis acoustic levitator, a half-wave 
aluminum Langevin stack actuated by piezoceramic transducers, with a nominal 
frequency of 29 kHz. By adjusting the stack to its resonance, a standing wave is formed 
in the air gap between the stack and a flat reflector placed a full wavelength away. The 




The housing is equipped with a thermocouple monitoring the inside temperature during 
the experiment.  
A drop is deployed manually near one of the pressure nodes via a syringe and a 
needle. An expanded He-Ne laser beam is incident on the drop, and a photodetector 
situated directly in the forward scattering senses the resultant light intensity. To decrease 
the sensitivity to ambient light, a narrow 632.8 nm optical bandpass filter is placed in 
front of the photodiode. To further increase our signal to noise ratio, a vertical slit of 300 
µm width is placed in front of the optical bandpass filter. 
Shape oscillations of the levitated drop are excited by amplitude-modulating the 
transducer drive signal. Figure 2.1 shows a schematic of amplitude modulation. Figure 
2.1(a) illustrates the acoustic field which holds the drop against the gravity. Figure 2.1(b) 
shows the modulation which excites the drop to undergo shape oscillation.  Figure 2.1(c) 
shows their superposition.  
The output voltage of the photodiode is linearly proportional to the area of the 
drop  [2](See appendix D for the derivation), where w 
and C1,2 are the laser beam radius and calibration constants, respectively. Thus, for small 
oscillations, the change in photodiode voltage  is linearly proportional to the change 
in radius , and thus the oscillatory strain , which for the present setup is 
approximated by a measured oscillatory strain , where a is the vertical radius 
and Δa is the change in the vertical radius. This was done not only because we have a 
vertical slit in front of the photodetector but also because real drops are always deformed 
into axisymmetric solids of revolution so that our vertical radius “a” corresponds to the  
2 2
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Figure 2.1. (a) A schematic of acoustic field which holds sample drop against the gravity. (b) 
Modulation field which excites the drop to undergo shape oscillation. (c) The superposition of 
acoustic and modulation field.  
 
semi-minor axis of symmetry. The added advantage of this method is that we are 
insensitive to lateral wandering of the drop in the levitator. In this configuration, we 
utilized camera observations of oscillatory strain amplitude to calibrate the photodetector 
voltage for strains in the range of 0.05–0.25. We employed a linear fit to extrapolate our 
photodetector voltage to strains smaller than 0.05. The backlit drop is monitored during 
the oscillation by using a digital camera.  
In order to infer material properties, we first apply the single degree of freedom 
harmonic oscillator model to the shape oscillations of drops in our experiments. Since the 




parameters, resonance frequency ωn and damping ratio z. There are two primary 
techniques for obtaining ωn  and z: the steady-state frequency response function (FRF) 
and the transient free decay (FD) techniques. In the FRF method, the modulation 
frequency is swept through the analytically estimated (using the Lamb equation for n = 2) 
quadrupole resonance frequency, and the steady-state response voltage x of the drop is 
recorded. By fitting the experimental response curve to the analytical FRF in Eq. (1), we 
may obtain best-fit estimates of ωn  and z,  
                (2.1) 
where x and A are the modulation frequency and driving amplitude, respectively. 
In the free decay method, a drop is initially excited into steady-state quadrupole 
oscillations, whereupon the modulation is turned off and the drop transient response x is 
recorded. Figure 2.2.(a) shows a levitated drop of glycerol-water solution which 
undergoes second mode of oscillation, and Figure 2.2.(b) shows the recorded response 
from photodiode. By fitting the experimental decay curve to the analytical decay in Eq. 
(2.2), we may again obtain best-fit estimates of ωn and z, 









æ ö æ öæ ö æ ö
ç ÷- + ç ÷ç ÷ ç ÷ç ÷è ø è øè øè ø
2cos( 1 )nt nx Ae t





Figure 2.2. (a) Time-average (>1 ms exposure time) image of a 1.4 mm radius drop of 20% 
glycerol in water solution undergoing large-amplitude (for illustration), resonant quadrupole 
modal shape oscillations with f = 75 Hz. (b) Normalized photodetector voltage vs time. (Credit: 
Without change from Ref. [142] under Creative Commons Attribution 4.0 International License  
https://creativecommons.org/licenses/by/4.0/) 
 
Knowing the resonance frequency and weighing the drop after each experiment as 
an alternative to using digital imaging for determining R, the surface tension can be 
obtained from the Lamb frequency for n = 2 (Ref. [128]), 
  (2.3) 
where m is the mass of the drop. Similarly, the viscosity is obtained from Eq. (2.4)[128], 
where R is the drop mass-equivalent radius 


















2.3. Multiple Peaks and Surface Tension Inference  
Trinh et al. [8]applied the oscillating drop method to infer the surface tension of 
an acoustically levitated drop. Sweeping the modulation frequency around the resonance 
frequency, they observed an interesting phenomenon. The frequency response function of 
the drop showed multiple peaks instead of one. Our experiments at finite amplitude 
modulation also show this phenomenon. As Fig. 2.3 illustrates, sweeping the oscillation 
frequency in the vicinity of the quadrupole mode frequency of the drop excites three 
different oscillatory behaviors. The first stage (Fig. 2.3(a)) is an oblate-prolate shape 
oscillation which is indeed the desired quadrupole mode oscillation and which yields the 
first peak in the FRF at roughly 62 Hz. Increasing the modulation frequency, a second 
stage, a “rocking” wave motion is observed (Fig.2.3(b)). Our photodetector is insensitive 
to this mode owing to the vertical slit in front of the photodetector. Upon a further 
increase in the modulation frequency, a final stage consisting of a traveling or a 
“running” wave mode is seen (Fig. 2.3(c)). Interestingly, this undesired mode produces 
the highest amplitude oscillatory signal peak at around 77 Hz. 
Trinh et al. [8]attributed these observations to the excitation of non-axisymmetric 
modes of oscillation. They hypothesized the non-spherical static shape, rotational 
movement of drop, or non-perfect symmetry of the levitation device caused the excitation 
of these modes. Later, Egry et al. [139]and Jamin et al. [129]also attributed this 
resonance frequency shifting and splitting to the rotational movement of the levitated 
drop or to a field-induced effect. Suryanarayana and Bayazitoglu [137]stated that the 




Trinh et al. [130]attributed this phenomenon to the nonlinearity of drop oscillations. 
Critically, what is common in all these studies is the claim that the oscillation 
amplitude of 10% is enough to be in the small amplitude oscillation regime, in agreement 
with the study by Becker et al[134]. To quantify our oscillation amplitude, we defined 
above the oscillatory strain . All the results in Fig. 2.3 are for a maximum strain of  = 
0.072 and thus roughly 7.2% to compare with others work. Our results in Fig. 2.3 show 
that even this 7.2% value of the oscillation amplitude is still large enough to excite non-
axisymmetric modes and multiple peaks in the FRF. For the case of Fig. 2.3, the 
theoretical Lamb quadrupole frequency of 68 Hz (computed using the known radius, 
density, and surface tension) does not correspond to either peak in the experimental finite 
amplitude FRF. If we were to pick one of these “wrong” peaks to apply Lamb’s formula 
to infer surface tension, we would have as much as 13% relative error in the natural 
frequency and consequently 26% relative error in the surface tension inference, owing to 







Figure 2.3. Finite-amplitude levitated drop response to the modulation frequency sweep from 57 
to 85 Hz. The solid dots are the calibrated oscillatory strain  obtained from the photodetector 
voltage. Three stages of forced drop shape oscillations are identified by horizontal arrows for a 
drop of a 20% glycerol-water solution, R = 1.44 mm, maximum strain  = 0.074, and theoretical 
Lamb frequency = 67.87 Hz. Single images are obtained with a continuous backlight and a 35 ms 
exposure duration, and the images are chosen for illustration purposes and correspond to higher 
strain amplitudes than the voltage data set. (a) Axisymmetric quadrupole shape oscillation at a 
modulation frequency of f ~ 62 Hz. (b) non-axisymmetric “rocking” shape oscillation at f ~ 70Hz. 
(c) Non-axisymmetric “running” shape oscillation at f ~ 77 Hz. 
 
 Fig. 2.4 shows that if the drop is excited with small modulation amplitude (strain 
amplitude  = 0.0045, below the resolution of our digital imaging), the FRF has only one 
peak, which coincides with the theoretical Lamb frequency. Also, the only observed 
oscillatory behavior of the drop is a quadrupole shape oscillation. The drop oscillation 
amplitude is too small to be distinguished precisely by using a camera, and so, we use the 









Figure 2.4. Small amplitude levitated drop response to the modulation frequency sweep from 57 
to 77Hz for a 20-wt. % glycerol-water solution. R = 1.41mm, maximum strain  = 0.0045, 
theoretical Lamb frequency = 70.04 Hz, and all other parameters as in Fig. 2.2. (a) Drop image at 
a modulation frequency of 60Hz, (b) 70Hz, and (c) 77Hz. 
 
Fig. 2.5 shows the strain dependence of the experimental quadrupole frequency, 
chosen as either the only peak in the FRF or the first peak in the FRF as shown in Fig. 
2.3. For data like those depicted in Fig. 2.4, where the oscillatory strain was not 
measurable by image but < 0.005, the observed frequency agrees well with the Lamb 
frequency. However, even choosing the “right” mode (the first peak in the FRF), the 
strain-dependent decrease in this frequency will result in an underestimation of the 







Figure 2.5. The ratio of the observed quadrupole mode frequency (first or only peak of the FRF) 
to the theoretical Lamb frequency vs. measured strain  . Data are binned with the bin width  
= 0.02. Error bars are ± one standard deviation. 
 
2.4. Excessive Dissipation and Viscosity Inference 
Using the oscillating drop technique to measure the viscosity of electrostatically 
levitated molten silicon drops, Ishikawa et al. [29]observed what they referred to as an 
apparent size-dependent trend in the inferred viscosity. Earlier, Trinh and Wang 
[135]plotted the free decay damping constant as a function of the maximum oscillation 
amplitude for drops of different sizes. They noted that one could perceive an increase in 
damping with increasing oscillation amplitude. We see the same apparent result in our 
free decay measurements. The open circles in Fig. 2.6 are the inferred viscosity (from Eq. 
(2.5)) vs drop size for finite amplitude (  = 0.12) oscillations. The data show a marked 
nonlinear increase in inferred viscosity with drop size, which we have fit with a quadratic 







Figure 2.6. Inferred viscosity of a 20 wt. % Glycerol-water solution vs. drop equivalent radius for 
both large (  = 0.12, open circles) and small (  = 0.006, closed circles) amplitude oscillation 
free decay experiments. Error bars represent one standard deviation, and the literature values have 
been interpolated linearly[143]. The quadratic fit for large amplitude data is the guide to eye and 
motivated by the paper by Ishikawa et al.[34]. 
 
Ishikawa et al. [34], [132]attributed this to the particular requirements of 
electrostatic levitation, which is not truly “static” since maintenance of drop stability 
requires an AC modulation of the electric field in addition to the modulation required to 
excite drop oscillations. They concluded that the sample size and position control 
parameters should be chosen so that not only should the control frequency be different 
from the sample oscillation frequency but also the control amplitude should be as low as 
possible; certainly, both are reasonable assertions. However, despite the fact that they 
used an optical scattering method similar to the method we use in this study, they have 
not reported the strain amplitudes used in their measurements. 
The inference of viscosity from a fluid almost always relies on a prescribed (and 





velocity field at finite amplitude excitation (no matter the source) deviates from the 
analytically assumed multipole eigen-fields inherent in the description of infinitesimal 
amplitude shape modal oscillations[128]. We investigated the internal flow of a drop 
during finite amplitude forced and free oscillations. To visualize the internal flow, 0.3 µm 
AlO2 particles (AlfaAesar Co.) are injected to the levitated drop while using simple 
backlighting. The observations show that by increasing the excitation frequency, at the 
first stage while the oscillation frequency is smaller, the four lobe configuration of the 
particles is observed (Figure 2.7(a)) as was also observed by Chung and Trinh[144]. 
Further increasing the excitation frequency, the second stage starts in which the drop 
symmetry axis makes an angle with the levitator axis. At this stage, the four lobe 
configuration disappears, and complicated, transient internal vortical motion can be 
observed, often culminating in an apparently solid-body rotation, illustrated by the tracer 
particles rotating around a horizontal axis (Fig. 2.7(b)). This large-scale vorticity persists 
through the last stage (Figure 2.7(b)), where the particles have experienced the solid-body 
rotation for so long that the dominant observable feature is the aggregation of particles 
along the new vertical axis of rotation (imperfectly wetted, irregular geometry AlO2 
particles trap gas, which makes many of the particles buoyant). However, rapid and 
smaller scale transient vorticity exists that is not visually apparent in these long 
exposures. The finite amplitude viscosity measurements (open circles in Fig. 2.6) show 
the result of this vorticity: the inferred viscosity will be apparently size dependent since 
the total dissipation is proportional to the volume integral of the vorticity[145], [146]. 




measurements. However, our results in Figures 2.6 and 2.7 show that only a small 
amount of organized vorticity is sufficient to contaminate viscosity measurements, and 
this is simply because the flow does not correspond to the idealized quadrupole 
oscillatory flow assumed in the Lamb theory[127]. 
 
 
Figure 2.7. The internal flow for three stages of large amplitude shape oscillation of drop of a 20 
wt. % glycerol-water solution containing 0.3 µm AlO2  particles similar to the open circle data in 
Fig. 2.4 (R = 1.3mm and maximum oscillatory strain  = 0.40, chosen for ease of illustration). 
Single images are obtained with a continuous backlight and a 35ms exposure duration. (a) 
Axisymmetric quadrupole shape oscillation, (b) non-axisymmetric “rocking” shape oscillation, 
and (c) non-axisymmetric “running” shape oscillation. 
 
Figure 2.8 shows the internal flow when the drop is excited at a moderate strain  = 
0.006. There is no observable vorticity for the resonant oscillations. When an inference of 
viscosity is made using these and smaller strains, the result is in agreement with the 
known literature values of viscosity, as illustrated by the closed circles in Figure 2.6, 








Figure 2.8. The internal flow of small amplitude shape oscillating drop of a 20 weight-percent 
glycerol-water solution undergoing quadrupole resonance oscillations containing 0.3 µm AlO2 
particles corresponding to the closed circle data in Fig. 2.4 (R = 1.3mm and maximum radius 
strain = 0.006). 
 
2.5. Surface Tension and Viscosity at Low Oscillation Amplitude 
In order to validate our assertion that the imposition of the small amplitude 
oscillation criterion is the key to achieving accurate material property results, we 
conducted a series of experiments on glycerol water solutions of varying concentrations.  
In all cases, the oscillations were monitored by laser scattering, and the oscillatory strain 
amplitude was small such that  ≤ 0.005. Figure 2.9 shows the inferred surface tension 






Figure 2.9. Surface tension and viscosity for different weight percentages of glycerol–water 
solutions obtained for small amplitude free-decay oscillations (  = 0.005). Numbers of samples 
vary between 24 and 42 drops at each concentration. Error bars represent one standard deviation, 
and the literature values are obtained by linear interpolation at room temperature. Open and 
closed circles show the experiment and literature values, respectively. 
 
In all but one case, the literature values fell within the precision error limits of the 
measurements (± standard deviation). Further, the mean values were accurate to within 








CHAPTER THREE: Application of the Technique to Sickle-Cell Disease 
Chapter Three is Reproduced Without change from “Shape oscillations of single blood 
drops: applications to human blood and sickle cell disease”, 8(1), Vahideh Ansari 
Hosseinzadeh, Carlo Brugnara and R. Glynn Holt, Scientific Reports (2018) [142], under 
Creative Commons Attribution 4.0 International License 
https://creativecommons.org/licenses/by/4.0/) 
 
3.1. Current Techniques to Study Sickle Cell Disease  
 
Sickle cell disease is one of the most commonly inherited diseases worldwide with over 
250,000 new births each year, and some 70,000–100,000 affected patients in North 
America[81]. In SCD, a point mutation occurs in the gene responsible for the production 
of the β-chain in hemoglobin (Hb), the main protein in red blood cells that is responsible 
for oxygen transport[82]. This mutation changes the hydrophilic glutamic acid to a 
hydrophobic valine amino acid residue in the β-globin chain gene, giving rise to 
hemoglobin S (HbS), a variant form of Hb. Under certain physiological conditions (e.g., 
deoxygenation) the sickle hemoglobin (HbS) can polymerize into long strands, resulting 
in stiffened and often sickle-shaped red blood cells [83]. Exposing cells to normal oxygen 
environment (normoxic) melts the fibers, but permanent and irreversible damage results 
from repeated exposure to alternating low-oxygen and normoxic environments [84]–
[87]and this may be a consequence of abnormal entry of Ca into the sickle red blood 
cell[88]–[91]. This irreversible membrane damage leads to stiffer sickle RBCs, which are 
unable to unsickle after re-exposure to normoxic environment (irreversibly sickled 
cells)[92], [93]. These RBCs may adversely affect blood flow [94]and contribute to 
vessel occlusion, poor oxygen transport, and hemolysis[95], [96]. Vasoocclusion is the 




ischemia/reperfusion cycles in various tissues, leading ultimately to progressive organ 
damage[147], [148]. Hydroxyurea (HU) has been until very recently the only FDA-
approved drug for treating SCD[99]. Studies show that HU-treatment increases fetal 
hemoglobin (HbF) production in RBCs [100]–[103]which inhibits the polymerization of 
HbS. However, several other additional mechanisms of action have been postulated for 
HU, including changes in endothelial NO metabolism. 
Various techniques have been used to study the rheological properties of SCD 
blood and to monitor HU treatment effectiveness on SCD care, such as cone-plate 
rheometry[102], co-axial cylinder viscometer[149], tube viscometry[148], common-path 
interferometric microscopy[99], Raman microscopy [150]and microfluidics flow 
resistance[151]. All these methods involve direct contact with the sample: thus, the 
measurements may be affected by the contact. For example, the clotting cascade can be 
artificially initiated[152]; local adhesion and resultant deformation of cells at the contact 
region can alter the cells functionally[153]. 
A classical solution to the contact problem has been to employ field-based 
levitation as a container-less method to position and manipulate cells [154]and biological 
samples[24]. Besides elimination of the contact effect, the levitation method also 
prevents any chemical and thermal contamination, i.e., adsorption from contact between 
sample and external objects[155]. The use of levitated sample droplets also has the added 
advantage of increased detection sensitivity since no walls disturb detection[156]. Optical 
interference at the walls of the container, which hampers detection when spectroscopic 




chip approach to miniaturization[157], the levitation technique exhibits similar benefits 
of diversity of application and low reagent and sample consumption, while also 
eliminating the risk of analyte adherence to walls and interfaces[156]. 
Subramanian et al. used magnetic levitation to measure metal-amplified changes 
in the density of beads labeled with biomolecules[158]. Andersen et al. detected cell-
membrane-bound and soluble antigens in magnetically levitated cells[159]. Engineered as 
a compact and portable unit, magnetic levitation was used to distinguish sickle RBCs 
from normal cells[160]. Jung et al. [161]optically characterized sickle cells using 
quantitative phase imaging. Zhong et al. [162]used optical tweezers to trap and 
manipulate red blood cells in vivo. Holt et al. utilized acoustic levitation to study the 
hemostasis of drops of whole blood[163]. Using acoustic levitation coupled with Raman 
spectroscopy, Puskar et al. studied malaria-infected cells[154]. Omrane et al. used the 
third and the fourth harmonic of a Nd:YAG laser to investigate elastic, fluorescence and 
phosphorescence signals from the levitated droplet and measure diameter variation 
(surface area), mixture concentration and temperature of the drop[155]. Lopez-Pastor et 
al. also levitated drops to monitor reactions in ionic liquids[164]. 
Here, we use acoustic levitation to study normoxic (normal level of oxygen) 
rheological properties of normal and SCD blood. A drop of whole blood is levitated in an 
acoustic field and excited to modal shape oscillation by amplitude modulation of the 
field. Using a laser scattering method, the free decay of the shape oscillation is measured, 
from which blood viscosity is inferred. Correlation of the measured viscosity with 




insights into the disease pathophysiology and the effectiveness of HU treatment. In 
particular, our results show that HU treatment reduces whole blood viscosity, and further 
that this viscosity reduction correlates with HbF production while exhibiting no 
correlation with mean corpuscular volume (MCV). 
 
3.2. Methods and Sample Preparation 
Our experiments were performed with the same single-axis acoustic levitator 
described before. The levitator is placed inside a housing which provides temperature and 
humidity control. All blood assays have been performed at relative humidity of 90 ± 10. 
0.9% Sodium Chloride Isotonic Saline is used as the aerosolized humidification material, 
to prevent osmolality changes in the levitated blood drop. Figure 3.1 shows a blood drop 
levitated in the acoustic field and a schematic of the experiment setup. 
 
Figure 3.1. (a) A 2 mm diameter (long axis) drop of whole blood is levitated in the resonant 
standing acoustic field in the air gap between the radiator (black bottom) of the Langevin stack 
and the reflector (bare Al cylinder top). (b) Schematic of the entire experiment. A drop of whole 
blood is levitated in the acoustic field (5). An expanded He-Ne laser beam (1) is incident on the 
drop, and a photodetector (2) senses the resultant fluctuating light intensity. The backlit drop by a 





In order to infer viscosity, we apply the single degree of freedom harmonic 
oscillator model to the shape oscillations of drops, as described in chapter two (Eq. 2.2). 
Knowing the resonance frequency ωn and damping ratio ζ viscosity is obtained from 
Equation (2.4). Blood density ρ as a function of Hct can be found from[165]. 
 
3.3. Normal blood assay as a validation of technique 
Acoustically levitated drops are excited to shape oscillation by amplitude 
modulation of the acoustic pressure. When the modulation is turned off, the drop 
undergoes free-decay oscillations. The free-decay technique has been calibrated in our 
previous study (chapter two) for viscous liquids. Here, we designed an assay that 
quantified the viscosity of whole blood versus hematocrit (Hct), the main factor affecting 
blood viscosity[166]. We performed the assay with only one volunteer’s blood (AA 
blood), to eliminate the existent variation between different biological samples. To 
validate our technique, blood viscosity was simultaneously and independently measured 
by cone-plate hybrid rheometer. Figure 3.2(a) shows the measured effective viscosity of 
normal AA blood by levitation and rotational rheometer. The results are in good 
agreement for all ranges of Hct. 
The relationship between blood viscosity and Hct has been previously empirically 
described by an exponential function as Aexp(k1Hct − k2T) in which A, k1, and k2 are 
constants. Hct and T are hematocrit and temperature °C, respectively[167], [168]. Along 
with this empirical formula, we use the Oldroyd-Einstein formula[169] (Equation (3.1)), 




Newtonian host fluid. In this way, the fit parameters can be directly used as the sample 
properties. In the theory, µ0 and Ф are the suspending medium viscosity and the 
dispersed-phase (RBC) volume fraction, respectively. For blood, µ0 and Ф represent the 
plasma viscosity and Hct, whereas β expresses the rate of viscosity variation vs. Hct. 
 
 
Figure 3.2. (a) The inferred viscosity of normal blood from a single volunteer by levitation 
(black) and rotational rheometer (red) measured at 37 °C and corrected to 23 °C to facilitate 
comparison with later results. Each point shows the average of 8 different drops (5–10 ml each) 
for the levitator, and 3 different samples (270 ml each) for the rheometer. Error bars in both cases 
indicate one sample standard deviation. The lines connecting the data are only guides for the eye. 
(b) Comparison of combined levitator and rheometer data (solid symbols), and the Oldroyd-
Einstein Equation (1) with µ0 = 3.5 mPas, and β = 28.8 mPas. 
 
On the assumption that both the rotational rheometer and levitation techniques 
yield (to within experimental uncertainty) essentially the same result, we pooled all 
normal blood data and fit them with the empirical and Oldroyd-Einstein formula, and the 
results are shown in Figure 3.2(b). Equation (3.1) accurately fits the measured 
relationship between viscosity and Hct with the fit parameters µ0 = 3.5 ± 0.6 mPas, and β 




  (3.1) 
 
3.4. Application of the Technique to SCD Blood 
Now that the levitator results have been validated by rotational rheometer, the 
effective viscosity of normal and SCD blood were measured and compared over a wide 
range of Hct values (Fig. 3.3). We varied Hct in each of the samples by manipulating the 
ratio of RBCs to plasma and obtained 3 different Hct values for each sample. Our 
experiments on 45 normal and 22 SCD samples show that at each Hct, SCD blood 
showed increased viscosity compared with normal blood. The fit parameters are as 
follows: µ0 = 3.4 ± 0.6 mPas and β = 15.01 ± 5.6 (normal samples), µ0 = 4.44 ± 0.9 mPas 
and β = 23.8 ± 9.1 (SCD samples). 
 
 
Figure 3.3. The measured viscosity at room temperature (23 °C) of 45 normal and 22 SCD blood 
samples using the levitator technique. Error bars show standard deviation, which shows variation 
among each sample. The curves show Oldroyd-Einstein fit for each data set to obtain 
characteristic values of µ0 and β. µ0 = 3.4 ± 0.6 mPas and β = 15.0 ± 5.6 mPas are parameters of 
the fitted curve of normal samples, µ0 = 4.4 ± 0.9 mPas and β = 23.8 ± 9.1 mPas are parameters of 










3.5. Effects of Hydroxyurea Treatment on Rheological Properties 
To assess the effect of HU on blood properties, we compared the properties from 
patients “HU-treated” and “HU-untreated”. We used only samples from patients on stable 
HU treatment, meaning that they had reached a therapeutic dose and were not exposed to 
dose changes. We did not use HU in vitro in any of the experiments. We varied Hct in 
each of the samples by manipulating the ratio of RBCs to plasma. By determining 
viscosity at 3 different Hct values for each sample, then fitting each sample with the 
Oldroyd-Einstein model Equation (3.1), we were able to extrapolate viscosity at a desired 
Hct value. Because of the strong influence of the erythrocyte concentration on the 
viscosity of blood, blood viscosity values are often normalized to a standard Hct of 45% 
by a regression equation[170], using 3 separate Hct values for each sample. In this study 
we used Equation (3.1) to calculate viscosity at 45%. As shown in Figure 3.4 HU 
treatment results in a significantly lower blood viscosity and this is consistent with 
previous studies[100], [171]. 
Studies show that the oxygen transport efficiency of SCD blood defined by Hct-
to-viscosity ratio (HVR) [86], [172]may be a more reliable indicator in assessing the 
response to HU treatment[173]. Because the oxygen-carrying capacity of blood is directly 
related to Hct value, and resistance to blood flow is inversely proportional to viscosity, 
HVR has been used as an estimate of “oxygen transport index”[86]. Figure 3.4 shows 
significant increase of HVR for “HU-treated”- compared to “untreated” patients, 
consistent with the earlier result[102]; this increase mirrors the corresponding decrease of 




HVR of about 5 [1/mPas] based on Figure 3.3 data. 
 
 
Figure 3.4. Adjusted (Equation 3.1) blood viscosity at Hct = 45% and HVR for both “HU-
treated” and “HUuntreated” patients. Error bars show standard deviation. Standard two-tailed t 
tests were used to determine the significance of the difference between two groups of data, where 
P < 0.001 and P < 0.01. 
 
3.6. Correlation of Rheological Properties with Clinical Measurements for 
Hydroxyurea Treatment 
Fetal hemoglobin induction [100]–[102]and increased MCV[100], [102], have 
been reported as two major effects of HU treatment, but there are limited reports of the 
rheological effects of these results. Figure 3.5 shows that there is a correlation between 
HbF and blood viscosity. Patients with higher HbF (expressed as total concentration of 
HbF in g/dl of blood) have lower adjusted viscosity, and thus a higher oxygen transport 
index HVR. This result is in agreement with previous studies, which reported the anti-
sickling effect of HbF on individual RBC[148], [174], which increases RBC 




hemoglobin in plasma[87], [176]–[180]. 
 
Figure 3.5. The adjusted viscosity at Hct = 45% (filled circles) and HVR (crosses) for SCD 
blood. Polynomial fits to the data are shown for both viscosity (Red) and HVR (Blue) as a guide 
for the eye. Same samples as Fig. 3.3. By increasing HbF, the adjusted viscosity decreases (P < 
0.01). The inferred Hct to viscosity ratio or oxygen delivery index versus HbF shows HVR 
increases by HbF (P < 0.0001). 
 
On the other hand, we did not observe any significant correlation between MCV 
and our measured rheological properties illustrated in Figure 3.6. Hct, and the 
corresponding variable Ф in Equation (3.1), are understood to be volume concentrations. 
As such, Hct = Ф ~ m × MCV, where m is the number density of RBCs in a given sample 
volume. Thus, to compare samples with varying MCV as in Figure 3.6 for a fixed Hct, m 
would have to be varied controllably. But this is the implicit assumption of the Oldroyd-
Einstein model, where concentration Ф is all that matters to the viscosity. Thus the 
apparent lack of correlation of viscosity with MCV in Figure 3.6 seems to support the 







Figure 3.6. The adjusted viscosity at Hct = 45%, and HVR for SCD blood vs. MCV. No 






CHAPTER FOUR: Application of the Technique for Blood Coagulation 
4.1. Current techniques to monitor blood coagulation 
Coagulation monitoring plays a key role in the management of coagulopathic 
diseases. Traditional approaches include induction of in vitro clotting of plasma (PT, 
aPTT, fibrinogen)[181] functional assays based on the use of chromogenic substrates 
(Anti-Xa assays)[182], and studies of platelet function and count[181], [183]. In the late 
1940s, Hartert introduced thromboelastography (TEG)[184], [185] to provide a time-
dependent assessment of whole blood coagulation. The device, virtually unchanged from 
its original inception in 1948, measures the torsional motion of a cylindrical pin 
immersed in blood. The blood is contained in a cup forced to execute oscillatory rotations 
of roughly ± 5°[186]. As the blood clots the rotational motion of the cup is transmitted to 
the pin, causing it to undergo torsional oscillations as well. TEG’s sensitivity to hypo- 
and hyper-coagulation defects associated with acute and chronic illness and surgery 
explains its longevity as a standard diagnostic tool in hospital laboratories[187]. 
TEG (or its direct competitors ROTEM) remains the gold standard for whole 
blood coagulation monitoring[188]. However, TEG suffers from certain well-documented 
drawbacks. Chief among these is the need for contact containment and manipulation of 
the blood sample. Blood contact with container walls has a strong effect on initiation of 
the coagulation cascade, even in the presence of calcium chloride (CaCl2), resulting in a 
sensitivity of coagulation tests to the type of materials and surface treatments used for the 
containment cup[189]. These effects also lead to widely variable clot rigidity and 




the clotting sample at the cup walls (Hartert calls the assumption of a no-slip wall 
boundary condition the “sine qua non” condition for TEG) is a well-known error 
source[126], [185], [193]. For instance, Fukada et al. reported[194] that with stainless 
steel cup, the clotting time at which G' and G" start to increase, was about 15 minutes. 
However, with a silicone coated surface, it was prolonged to longer than 20 minutes. The 
clotting time with an Avcothane coated surface was longest. The value of G' was smallest 
for the Avcothane coated surface. The difference in clotting time suggests the difference 
in enzymatic reactions on the surface of coating materials. The difference in rigidity 
suggests the difference in structure of the clot and also in the adhesiveness of the clot to 
the surface of material. And, the other research study[191] showed that the spontaneous 
coagulation of native whole blood on a methylated surface is known to bind proteins 
firmly; especially fibrinogen is adsorbed almost irreversibly onto hydrophobic surfaces. 
However, the association of more proteins onto an initially adsorbed monolayer is low. It 
can therefore, be concluded that platelet surface adhesion and spreading play an 
important role during the blood-surface interactions and thereby influence the Surface 
plasmon resonance (SPR) signal. A similar finding was reported by Hong et al. [195]who 
quantified surface associated coagulation of human blood plasma with a developed 
methodological system consisting of a Quartz Crystal Microbalance with Dissipation 
monitoring (QCM-D), a method that measures the weight of adsorbed molecules on 
surfaces as a function of frequency shifts of a quartz crystal. Further, it measures the 
damping energy (i.e. viscoelasticity) of the adsorbed layer. They observed that contact 




place rapidly, and while for hydrophobic polymers, contact associated activation is 
prolonged. In fact, according to the classic mechanism of the intrinsic pathway, 
coagulation is triggered by contact activation of the plasma serine protease FXII when 
exposed to a negatively-charged surface with prekallekrein and kininogen, followed by 
sequential activation of FXI and FIX[196]. When blood is exposed to artificial surfaces, 
properties such as hydrophilicity and the presence of ionic groups on the surface in 
contact with blood plasma play a key role in activating the intrinsic pathway; in 
particular, hydrophilic anionic surfaces have been reported to induce more rapid 
coagulation than hydrophobic and cationic surfaces[197], [198]. 
In addition to container contact effects, it is pertinent to recall that the TEG’s 
principal drawback is that the strain amplitude associated with its operation is 
uncontrolled and decreases progressively during the course of coagulation. Typical TEG 
measurements involve shear strain amplitudes in the range 8–16%, which are 
substantially greater than those commensurate with linear viscoelastic behavior. As the 
TEG transgresses the non-linear viscoelastic regime, its operation can substantially delay 
clot formation[199], and limits the ability of TEG to elicit true physical properties of the 
clot, both because such strain amplitudes involve nonlinear elastic responses, and the 
motion of the device lyses the clot shortly after it forms[194], [199]. Furthermore, TEG 
infers clot ‘rigidity’ solely from the peak rotational amplitude of the pin. Since both 
elastic and viscous contributions from the coagulating blood can result in pin motion, 





Several alternative techniques to TEG have emerged. By eliminating the pin, 
Ungerstedt et al. [201]measured freely decaying oscillations of the sample-containing 
cup (‘free oscillation rheometry’ or FOR). Viola et al. [202]and Xu et al.  [203]used the 
acoustic radiation force (ARF) to locally strain the sample and directly measured the 
resulting displacement strain. Wang et al. [204]added microbeads to enhance both the 
ARF and the detection of strain. Instead of measuring strain directly, so-called dynamic 
ultrasound elastography (DE) techniques measure the propagation of a shear wave 
induced by a short acoustic pulse[193]. Despite the fact that the foregoing examples 
represent improvements to TEG, they all continue to require contact containment of the 
sample. 
A non-contact approach to coagulation measurement was introduced by Holt et al 
[163].This method, referred to as “quasi-static acoustic tweezing thromboelastometry” 
(QATT), inferred changes in tensile elasticity (elastic modulus or firmness) of a 
coagulating drop of blood by employing imaging to measure its static deformation during 
acoustic levitation.  
The clotting of blood takes place by fibrinogen-fibrin transformation by the 
thrombin and the subsequent polymerization and network formation of fibrin. With the 
progress of blood clotting, the rigidity and viscosity of blood increase, related to the clot 
structure of fibrin. The measurement of dynamic viscoelasticity is an important technique 
for investigation of blood clotting. 
Here, we apply dynamic drop oscillation rheometry (DOR), which is capable of 




4.2. Methods and Sample Preparation 
Discarded and de-identified citrated whole blood samples collected for 
specialized coagulation experiments were used for this study under a Human Study 
Protocol approved by the Institutional Review Board of Boston Children’s Hospital with 
a waiver of consent. TEG and DOR assays were performed simultaneously within 2 
hours post sample collection. Citrated blood samples were incubated with 0.02 M CaCl2 
(ratio identical to TEG 340/20 µl) at 37 °C for 2 minutes prior to the assay. Platelet rich 
plasma (PRP) and platelet poor plasma (PPP) were obtained by centrifuging whole blood 
at 1000 and 3000 rpm, respectively. 
Polyacrylamide/bisacrylamide (2% v/v) gel, was prepared by adding 1.25 mL 
40% Acrylamide solution (BioRad, Hercules, CA, USA) with 32 µL 2% Bis solution 
(BioRad). The polymerization was initiated by adding and mixing gently 100 µL 
ammonium persulphate (Sigma-Aldrich, St. Louis, MO, USA) and 20 µL TEMED 
(Sigma-Aldrich). 
 
4.3. Theoretical Modeling 
Similar to the previous chapter, we measure two parameters from experiment, 
resonance frequency (ωn) and damping ratio (z). To relate the rheological properties to 
the measured resonance frequency and damping ratio, we employed the approach of 
Pleiner et al. and Temperton et al. [205], [206] , who considered the dispersion of 
capillary waves on the surface of a semi-infinite viscoelastic medium.  




half-space z < 0, with the boundary at z = 0 separating the material from a dilute gas or 
vacuum (Figure 4.1). Thermal fluctuations or externally applied perturbations are 
assumed to induce small amplitude oscillation. The nature of these modes is determined 
by a competition between surface capillary effects and internal bulk viscoelasticity. 
The semi-infinite medium assumption is justified here because the radius of the 
droplets is typically two orders of magnitude larger than the amplitudes of vibration. For 
the range of droplet radii studied (1–1.5 mm), the amplitudes were typically observed to 
be less than 0.01 mm respectively. As discussed in chapter two, we were not able to see 




Figure 4.1. Viscoelastic surface wave configuration[205]. 
 
To obtain the surface modes, Pleiner et al. [205] solved a linearized Navier-
Stokes type of equation subject to boundary conditions on the air-material interface. The 
equation has the form 
   (4.1) 
where r0 is the material density, vi is the i-th component of fluid velocity, P is the fluid 
















conditions at the surface, the tangential component of total stress must vanish and the 
normal component of total stress must balance the Laplace pressure of the interface 
 and                                                                             (4.2) 
where σ is the surface tension of the interface and z(x) is the z-component of the local 
surface displacement from equilibrium. Within the Maxwell fluid model, the form of 
σij(ve) is similar to the ordinary viscous fluid stress tensor; we only replace η0 with its 
complex frequency-dependent form in the stress tensor 
             (4.3) 
Using the continuity equation and noting that small pressure and density gradients 
are related by sound velocity in the medium, we have . In order to obtain 
solutions to the resulting equations of motion that decay exponentially into the medium 
and satisfy the boundary conditions, we take linear combinations of longitudinal and 
transverse wave solutions. We assume these to be of the form  
  (4.4) 
with q  for the transverse or longitudinal mode, respectively. Eq. (4.5) is the dispersion 
relation for semi-infinite viscoelastic medium described by Pleiner et al. [205]: 
  (4.5) 
Where  is a complex kinematic viscosity. This result is quite familiar in 
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relation for capillary waves on a purely viscous liquid with surface tension σ; while by 
replacing ν(ω) with   and setting σ = 0, we get the dispersion relation for 
Rayleigh elastic surface waves. Following the derivation by reference [206] and using 
slightly different notation, we have the following approximation based on Taylor 
expansion. 
  (4.6) 
Substituting Eq. (4.6) in Eq. (4.5) and simplifying the equation, we have 
  (4.7) 
Now we replace the following equations in Eq. (4.7): 
 , and         (4.8) 
To obtain 
  (4.9) 
Rearranging the parameters, 
  (4.10) 
We separate real and imaginary parts of right-hand side of Eq. (4.10). 
  (4.11) 
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  (4.12) 
 
The allowed values of the wave-vector, k, of surface vibrations at resonance are 
determined by the requirement that an integer number of vibrational wavelengths, λ, fit 
around the periphery of the droplet. This gives the result that nλ = 2πR, where n is a 
mode number and R is the radius of the drop. We therefore obtain values of k as 
 . Inserting this result into Eqs. (4.11), (4.12), we have the storage and loss 
moduli G’ and G” as: 
  (4.13) 
  (4.14) 
Dynamic viscosity can be determined from the loss modulus G” as follows: 
  (4.15) 
In the case of a Newtonian liquid droplet, where G’=0, we have from Eq. (4.2)  
                                                                                 (4.16) 
Substituting Eq.(4.16) in Eq.(4.14) 
                                                                                                      (4.17) 
And, we know that  
2 2 3
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  (4.18) 
Equating Eq. (4.17) and Eq. (4.18) 
  (4.19) 
This approximates favorably with the exact solution for a viscous sphere for the second 
mode (n = 2), derived by Lamb[128] (Eq. (C.25)) 
                             (4.20) 
 
For the case of a perfectly elastic sphere with no dissipation, we would expect surface 
tension effects to be negligible and the loss modulus to be zero, i.e. σ = 0 and G” = 0. 
This predicts that the frequency of vibration of the sphere is given by: 
                                                                                         (4.21) 
 
This approximates the speed of sound in the material (With factor of √2) [207] 
( ), 
  (4.22) 
 
4.4. Polyacrylamide Gel Assay as a Benchmark 
Unlike simple synthetic polymer gels, many biological materials, including fibrin 
gels (the key protein involved in blood clotting) have nonlinear elasticity characterized by 





























appears essential for their function as haemostatic plugs[208], [209]. While the principal 
mechanism for this nonlinear elasticity is unknown, it has been conjectured that stiff 
fibers are easier to bend than to stretch, and therefore as strain increases and the filaments 
align more in the strain direction, a transition occurs from bending to stretching modes, 
which leads to increased stiffness at increased strains[208]. 
In order to avoid this strain-dependent rheology, we performed an assay which 
uses polyacrylamide/bisacrylamide (2%) gel polymerized with ammonium persulphate 
and tetramethylethylenediamine (TEMED). The Bis concentration in solution was chosen 
so that we were just able to deploy a spheroidal drop using a syringe/needle combination. 
Higher Bis concentrations could not be used with this technique. Using the 
experimentally measured drop shape frequency and damping, storage modulus G’ and 
loss modulus G” were calculated. Figure 4.2 shows rotational rheometer results for G’ 
and G” of the gel plotted as a function of the percentage strain γ at 10 rad/s. As expected, 
the gel shows no strain dependence over three orders of magnitude of strain. At a single 
frequency (that of free decay) DOR results are within 2 Pa of the rotational rheometer. 
Temperton et al. [206] also showed a good agreement between the results of rotational 
rheometry and drop oscillation rheometry for Polyacrylamide Acrylate in the range of G’ 





Figure 4.2: Loss G’’ and storage G’ moduli of 2% polyacrylamide/bisacrylamide as a function of 
percentage strain at 10 rad/s using a cone-plate rotational rheometer. Red and black data points 
are measured by levitation technique. Mean ± SD of 5 drops. The commercial rheometer data are 
mean ± SD of 3 runs.  
 
4.5. Whole Blood Coagulation: DOR Response Depends on Platelets, Fibrinogen and 
Calcium Ions 
The role of platelets in hemostasis has been well-established[210], [211]. In order to 
assess the DOR dependence on platelets, we compared the coagulation profiles of platelet 
rich (PRP) and platelet poor plasma (PPP). The results in Figure 4.3 demonstrate that 
PRP has higher clot stiffness than PPP, in agreement with previous studies[212]. Heat 
inactivation (30 min at 56°C, see ref[213]) of normal control plasma destroys fibrinogen 
and heat labile coagulation factors. As shown in Figure 4.3(a), this treatment results in 






Figure 4.3: (a) The magnitude of the complex modulus |G| = (G’2 + G’’2)1/2 vs time for platelet 
poor plasma (PPP), platelet rich plasma (PRP), and heat-inactivated plasma. Mean ± SD of five 
drops of one sample. (b) Storage (G’10) and loss (G”10) modulus evaluated at t = 10 min vs. 
platelet concentration in plasma. Post-test visual observation of levitated samples was used to 
confirm the absence (“No – Clot”) or presence (“Clot”) of clotting. Mean ± SD of three drops of 
one sample. 
 
The effect of CaCl2 (used to recalcify sodium citrated blood and plasma) on DOR 
coagulation measurements was also studied. Figure 4.4(a) shows that 0.58 mM CaCl2 
results in a small but measurable modulus magnitude |G| ~ 50 Pa in a whole blood 
sample. However, visual inspection showed no gelation. Increasing CaCl2 to 0.96 mM 
initiated coagulation (according to visual inspection), and resulted in a higher modulus 
magnitude |G| ~ 150 Pa at 20 minutes. Interestingly, increasing CaCl2 beyond 0.96 mM 
had no discernible effect on the modulus. A similar trend was seen for PRP (Fig. 4.4b). 
These results are in agreement with Brass et al. [214]who reported that calcium decreases 
the time required for fibrin formation from fibrinogen by markedly accelerating the phase 





Figure 4.4: The magnitude of the complex modulus |G| vs time for coagulation of whole blood 
(a) and PRP (b) for varying concentrations of CaCl2. Mean ± SD of five drops of one sample. 
 
4.6. Whole Blood Coagulation: DOR Is Sensitive to Hematocrit 
Erythrocytes are known to be a key component of clot formation, but their effect 
on in vitro coagulation is not fully understood. While a few studies show that increasing 
Hematocrit (Hct) increases coagulation rate and clot stiffness [215]–[218]others reported 
an opposite effect[219], [220]. 
One hypothesis to explain these contradictory results places the blame on contact 
activation during TEG measurement[219]. Using DOR we studied the effect of Hct on 
blood coagulation in a non-contact environment. We added washed RBCs to PRP and 
PPP and adjusted the hematocrit to 45% to mimic the original Hct of the autologous 
blood. Previously, Figure 4.4b showed that a CaCl2 concentration of 0.54 mM was not 
adequate to initiate coagulation in both PRP and PPP. Strikingly, Fig. 4.5 shows that 
when RBCs are present in the sample, a 0.54 mM concentration of CaCl2 is sufficient to 
initiate coagulation in both PRP and PPP. 
To determine Hct dependence in a PPP sample, samples were reconstituted by 




between 5% and 45%. Fig. 4.6 shows that clot stiffness increased with increasing Hct. 
For Hct below 20% coagulation did not occur, while it did for Hct higher than 30%. 
Eugster and Reinhart [218]also showed that no occluding platelet plug was formed in a 
PFA (platelet function analyzer) at Hct 20% and lower. 
 
 
Figure 4.5: The magnitude of the complex modulus |G| vs. time for whole blood (WB, 45% 
Hct)), platelet poor plasma (PPP), platelet rich plasma (PRP), and added red blood cells (PRP + 
RBC and PPP + RBC) to achieve 45% Hct. All samples were prepared as the ratio of 0.54 mM 
CaCl2. Mean ± SD of five drops of one sample. 
 
 
Figure 4.6: Storage (G’10) and loss (G”10) modulus evaluated at t = 10 min vs washed RBC 
concentration in platelet poor plasma (PPP) (n=2). From each volunteer, three drops at each Hct 
were recorded. Post-test visual observation of levitated sample drops was used to confirm the 
absence (“No – Clot”) or presence (“Clot”) of clotting. At Hct of 20% and 25%, clotting occurred 




4.7. Comparison of DOR and TEG 
Having established DOR’s sensitivity to changes in the elements of coagulation, 
we established a direct comparison of our results with TEG. Figure 4.7 shows a typical 
TEG thromboelastogram (left) and the associated measured parameters. ‘R-time’ is the 
time from initiation of the assay to 2 mm clot formation. The K value is the time from 2 
mm to 20 mm of clot formation. The ‘maximal amplitude’ (MA) represents the overall 
clot strength and is a measure of platelet activity[212]. 
 
 
Figure 4.7: Direct comparison between TEG (a) and DOR (b). In TEG R-time is the time taken 
for the output s to reach 2 mm and K-time is the time from R-time until s = 20 mm. The 
maximum amplitude (MA) is the maximum of oscillatory deformation s. DOR calculates |G|, the 
magnitude of the complex modulus, vs time during blood coagulation. R-time is defined as the 
time required for |G| to increase 10 Pa from its initial value. K-time is the time taken from R-time 
until |G| = 125 Pa. GMax shows the maximum |G| during the clotting cascade. Mean ± SD of three 
drops. 
 
To convert TEG output (s) to G, we use a formula described by Hartert[185], in 
which s [mm] is the measured amplitude in the thromboelastogram and GTEG [dyne/cm2] 
is the shear modulus inferred by TEG (Eq.(4.6)). 









Using Eq. (4.6), the corresponding GTEG value for each TEG parameter can be 
calculated. Thus, R-time is the time taken for GTEG to increase 10 Pa from its initial state. 
Similarly, for K-time, s = 20 mm corresponds to GTEG = 125 Pa. Finally, substitution of 
MA for s results in a maximum value GTEG,Max which will be different for each sample. 
Burghardt et al. [199]cast doubt on the accuracy of Eq. (4.6) introduced by 
Hartert[185]. According to this equation, an infinitely rigid clot would give an amplitude 
of 100 mm, and suffer no strain since the cup and pin would move together with exactly 
the same angular displacement. They mentioned that this equation has been adopted by 
others for measurements of modulus as a function of time using the TEG[200], [221], 
[222]. (In practical terms, it should be noted that 100 mm is beyond the range of the strip 
chart, and that a highly rigid sample causes the TEG to go off scale). 
However, we use this formula to be able to compare TEG and DOR by equating 
GTEG and G. Figure 4.6 (right) shows that R and K were obtained from DOR data by 
finding the times for the corresponding GTEG values as shown on the graph. We equated 
the quantitative values of GTEG, which is a shear elastic modulus, with the magnitude of 
the complex (shear) modulus G. As can be inferred from Figure 4.6, the storage modulus 
G’, which represents the elastic component of the complex modulus, is an order of 
magnitude greater than the loss modulus G” for whole clotting blood, justifying our 
approximation. 
Figure 4.8 shows the ratio of TEG parameters to DOR parameters (TEG/DOR). 
Comparing the parameters shows that the measured R-time from TEG is about 20% 




delay in the coagulation process to Cyrolite, the material used for the TEG-cup. The TEG 
coagulation rate (K-time) is roughly 40% higher than that found by DOR. Finally, the clot 
firmness Gmax is fully three times higher in TEG vs DOR. In the literature, there are some 
inconsistencies among measurements of maximum clot stiffness. Using the LSR method, 
Tripathy et al.[117] measured the clot stiffness of ~700 Pa, while Kaibara et al. 
[190]measured it around 200-300 Pa using a custom linear shear oscillatory rheometer. 
We attempted to employ a standard commercial rotational rheometer (HR-2, TA 
Instruments, MA) for additional measurement of clot firmness, but it did not produce 
reliable or repeatable results owing to the need for careful management of the contact and 
free surface conditions. When no free surface treatment was employed, a scab formed 
around the lower plate, yielding unreasonably high values for G’ (~20,000 Pa). When 
mineral oil was employed to prevent evaporation and scab-formation, the plate surface 
contact was compromised, yielding unreasonably low G’ values (< 100 Pa). We 
concluded that it was far easier to obtain reliable results for blood using our DOR 
technique, which at least agreed to within a few Pa with the commercial rheometer for the 






Figure 4.8: Comparative analysis of coagulation parameters measured by TEG and DOR. Mean 
± SD of 50 samples. 
 
 
To distinguish both elastic and viscous contributions in blood coagulation, we 
obtained loss modulus G” during the clotting cascade. Figure 4.9 shows the variation of 
G” versus time during clotting of a whole blood sample. As the blood clots, the loss 
modulus increases until the clot is fully formed. Once the fibrin network is fully formed 
and cross-linked, there is no more fluid flow in the sample, hence dissipation as measured 
by the loss modulus G” starts to decrease (Figure 4.9, at roughly 20–25 minutes), while at 
the same time the stiffness as measured by the storage modulus G’ begins to level off 





Figure 4.9: Change in loss modulus G” during whole blood coagulation measured by the DOR 
technique. 
 
4.8. DOR: Normal Ranges and Detection of Abnormal Samples 
Haemonetics® suggests that every clinical laboratory establish its own normal ranges for 
each of the TEG parameters. The laboratory of Boston Children’s Hospital provided the 
following values as normal ranges: 5–10 min for R-time, 1–3 min for K-time, and 50–70 
mm for MA. Using these values to restrict the sample size to a population defined as 
“normal”, we define the mean-healthy and the 95% confidence interval “CI95healthy” as 
mean ± 2SD based on the assumption of Gaussian statistics for each metric. Table 1 





Table 1. The mean and 95% confidence interval of normal samples (Normal samples fall within 
normal ranges provided by Boston Children’s Hospital quoted in the text) (nNormal = 28) 














R-time[min] 6.48 4.2 – 8.76 11 5.45 3.19 – 7.71 1 0.0008 
K-time[min] 1.54 0.8 – 2.28 22 2.77 0.23 – 5.31 1 < 0.0001 
GMax [Pa] 680.06 535.8 – 824.8 22 224.68 158.5 – 290.8 1 < 0.0001 







CHAPTER FIVE: Discussion and Conclusions 
Acoustic levitation has a long history of application to infer material properties. 
Our results allow us to make some immediate suggestions to the researchers who employ 
drop shape oscillations for inferring material properties. First, minimize oscillatory strain 
amplitude. This single factor has shown itself to be at the heart of a host of seemingly 
unrelated dynamic observations and incorrect material property inference. Our results 
show both mode-splitting and vorticity can be avoided by keeping the oscillatory strain 
amplitude below 0.005 or half a percent. This leads us to a practical diagnostic suggestion 
for the oscillations: instead of a camera, use a more sensitive means of oscillation 
detection, such as the optical scattering method used here. Certainly, optical scattering 
can be made even more sensitive with coherent techniques (interferometry), but the 
tradeoff is the requirement for a more sophisticated and noise-sensitive apparatus. There 
exist software-based techniques for extracting sub-resolution motion from images[223], 
but they do not seem to be suited to transient motion unless a high-speed imager is used, 
thus again adding a requirement for more expensive apparatus. The photodetector, digital 
camera, scattering diode laser, and imaging light source used in this study all together 
were available for less than $1000. 
But how good is this drop shape oscillation technique? The answer to that 
question depends on the damping ratio of the drop eigen-mode: the lower the damping 
ratio, the better the measurement. This is mostly owing to the decrease in usable 
oscillation cycles in the free decay with the increasing damping ratio, as other researchers 




corresponds to an Ohnesorge number Oh ≤ 0.04 (corresponding to a viscosity of 6× 
water for water-like drops of order 1mm), our surface tension and viscosity results 
achieve better than 4% in both precision (which can be lowered by increasing the number 
of samples) and accuracy. 
Applying the acoustic levitation technique to infer blood viscosity shows that the 
technique is capable of measuring the viscosity of blood over a wide range of Hct. The 
results were in a good agreement with commercial rotational rheometry.  Our results 
indicate that the acoustic levitation-based measurement of whole blood viscosity may 
serve as a convenient biomarker for the altered rheology of sickle cell disease. This 
marker is rapidly attainable from a single drop of blood. Additionally, we demonstrate 
that drop shape oscillations can measure changes in viscosity that is associated with the 
clinical use of hydroxyurea. We also show that these changes in viscosity are correlated 
with the total amount of HbF present in each sample, while they are independent of the 
increase in MCV that is observed with hydroxyurea therapy. Thus, this technique may 
hold promise for assessing changes in blood viscosity in sickle cell and other 
hematological diseases. 
There is a growing recognition that a variety of pathological conditions can lead 
to changes in blood viscosity. Medication-induced[224] states  and bacterial or viral 
infections [225]have been shown to change viscosity. Although various techniques can be 
used for the measurement of rheological properties of biological fluids, acoustic 
levitation is unique in being capable of providing rheological information for biological 




The results also indicate that the increased viscosity of whole blood in SCD is not 
simply due to changes in RBC volume and cellular dehydration. Membrane damage of 
the individual RBC can play a role in the overall blood viscosity. We are intrigued that 
plasma viscosity (represented by µ0 in Equation (3.1)) may also contribute, at least in 
theory, to determine SCD blood viscosity. Future studies will address the role of these 
variables. The dependence of viscosity on HbF and the overall improved viscosity of 
samples collected from patients on stable HU therapy provide a strong indication that our 
experimental approach reflects the pathophysiology of the disease and could be used to 
quantify beneficial changes induced by HU or other therapies. 
Coagulation metrics can be population-normalized as in Table 1 to demonstrate 
that DOR, like TEG, can be useful to describe coagulation norms for diagnosis purposes. 
However, there remain significant differences in the actual mean values of comparable 
coagulation parameters R-time, K-time and Gmax. As we discussed in chapter four, the 
contact requirement of TEG (and other similar techniques) is very likely at the heart of 
the R-time difference. But TEG has always required kaolin to increase the coagulation 
rate (thus reducing K-time) and thus bring the total test time within 30 minutes. Finally, 
the larger maximum stiffness exhibited by TEG vs. DOR may partly be explained by 
surface contact effects. Surface contact activates platelets which in turn secrete 
polyphosphate, leading to thicker fibrin fibers that are more resistant to fibrinolysis[226]. 
This is also consistent with Ostomel et al. [227]who find that clot stiffness depends on 
oxide charge effects. 




DOR, sample containment and manipulation are accomplished by the acoustic field with 
no mechanical contact. The measurement results show that clotting as measured by DOR 
is sensitive to the concentration of platelets, calcium ions, red blood cells, and fibrinogen 
presence. When compared to TEG, DOR is able to reproduce the results of TEG, while 
also providing information about dissipative effects (G’’) and their evolution during 
clotting. DOR, like its previously reported static counterpart QATT[163], requires only a 
single drop of blood. 
We conclude the acoustic levitation technique allows us to overcome the 
difficulties associated with contact containment and large sample volume that plague 








A. MATLAB Code – Non linear least square fit 
Using non-linear least square method, this MATLAB scripts fits the equation of 
 to the recorded free-decay from the photo-diode. 
 
N = length(x); 
Zz = x (28350:34000); 
Zzz = zz ./ max(zz); 
deltaT = 1/25000; 
t = 0 : deltaT : ((length(zz) - 1) * (deltaT));  
plot(t',zzz); hold on;  
A0 = 0; A1 = 0.65; 
w0 = 50:0.01:65; 
zeta = 0.04:0.001:0.05; 
  
for p = 1:length(zeta); 
     for n = 1:length(w0); 
         AA = A0 + A1 * (exp (-zeta(p) * 2 * pi * w0(n) * t)) .* cos(2 * pi * w0(n) * 
sqrt(1-(zeta(p)^2)) * t);  
        Am = max(AA);  
        A = AA/Am; 
         Magerr = abs(zzz') - abs(A); 
         me2=magerr .^ 2;  
        sme2(n,p) = sum(me2);  
    end  
end 
 
[ival iind] = min(sme2); 
 [jval jind] = min(ival); 
err = sme2(iind(1),jind); 
 w0_calc  =  w0(iind(1)) 
zeta_calc  =  zeta(jind) 
wd_calc =  w0_calc * sqrt(1-(zeta_calc ^ 2)); 
alpha_calc  =  zeta_calc * w0_calc * 2 * pi 
A_f = A0 + A1 * (exp(-alpha_calc * t)).* cos(2 * pi * wd_calc * t); 
plot(t, A_f ./ max(A_f),'r') 
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B. MATLAB Code – Edge detection 




I = imread('1-1.bmp'); 
figure; imshow(I), title('Original image') 
upper_threshold  = 0.3; 
filter_size = 50; 
bw = edge(I,'canny',[0 upper_threshold],filter_size); 
se = strel('disk',1,0); 
dilated = imdilate(bw,se); 
filled = imfill(dilated, 'holes'); 
imshow(filled) 
smoothed = imerode(filled,se); 
border_clear = imclearborder(smoothed); 
threshold_size = 10; 
bw = bwareaopen(border_clear, threshold_size); 
[B,L] = bwboundaries(bw,'noholes'); 
hold on 
for k = 1:length(B) 
  boundary = B{k}; 
  plot(boundary(:,2), boundary(:,1), 'w', 'LineWidth', 2) 
end 
stats = regionprops(L,'all'); 
threshold = 0.94; 
for k = 1:length(B) 
  
    boundary = B{k};   
  area = stats(k).Area;   
  a = [stats(k).MajorAxisLength];  
  b = [stats(k).MinorAxisLength];    
  x = [stats(k).Centroid(1)];   
  y = [stats(k).Centroid(2)]; 
end 
line(x, y , 'Marker', '*', 'MarkerEdgeColor', 'r') 








C. Drop Resonance Frequency and Damping Ratio (Theory)[128] 
Taking the origin at the center, we define the shape of the common surface at any instant 
be given by 
  (C.1) 
Where a is the mean radius, and Sn is a surface-harmonic of order n. The corresponding 
values of the viscosity-potential will be, at internal points, 
  (C.2) 
And, at external points, 
                                                                                      (C.3) 
 
Since these make    
For r = a. The variable parts of the internal and external pressures at the surface are then 
given by 
,                                       (C.4) 
To find the sum of the curvatures we make use of the theorem of Solid Geometry that if 
λ, µ, ν be the direction-cosines of the normal at (x, y, z) to that surface of the family 
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                                                                                            (C.5) 
then 
  (C.6) 
Since the square of  is to be neglected, the equation (C.1) of the harmonic spheroid may 
also be written 
  (C.7) 
Where 
  (C.8) 
i.e.  is a solid harmonic of degree n. We thus find 
  (C.9) 
Whence 
  (C.10) 
Substituting from (C.4) and (C.10) in the general surface-condition, we find 
  (C.11) 
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If we put , this gives 
   (C.12) 
 
Damping ratio 
When viscosity is neglected, the velocity-potential in any fundamental mode is of the 
form 
  (C.13) 
Where Sn is a surface-harmonic. This gives for twice the kinetic energy included within a 
sphere of radius r the expression 
  (C.14) 
If  denote an elementary solid angle, and therefore for the total kinetic energy 
  (C.15) 
The potential energy must therefore be 
  (C.16) 
And the total energy is 
  (C.17) 
Again, the dissipation in a sphere of radius r, calculated on the assumption that the 
motion is irrotational, is 
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  (C.18) 
Now 
  (C.19) 
Each side, when multiplied by , being double the kinetic energy of the fluid 
contained between two spherical surfaces of radii r and . Hence, from Eq. (C.14) 
    (C.20) 
Substituting in Eq. (C.18), and putting r = a, we have, for the total dissipation, 
  (C.21) 
The mean value of which, per unit time, is 
  (C.22) 
If the effect of viscosity be represented by a gradual variation of the coefficient A, we 
must have 
  (C.23) 
Whence, substituting from Eqs. (C.17) and (C.22), 
  (C.24) 
This shows that  , where 
  (C.25) 
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D. Laser Scattering [2] 
A levitated drop is oscillating near the pressure node of an acoustic levitator. It is placed 
in the path of a He-Ne laser beam. There is a variable magnification laser beam expander 
in front of the original laser beam. The laser beam, the drop, the aperture and the laser 
filter must be aligned. By amplitude modulating of the acoustic field, the levitated drop 
starts to oscillate. Drop oscillation changes the intensity of transmitted light to the 
photodetector. In this section, we derive the relationship between the signal from the 
photo-diode and drop oscillation. 
We make some assumptions here. First, it is assumed that there is no eccentricity 
effect of the levitated droplet after alignment; second, the droplet is axisymmetrically 
deformed, because only the projection of the droplet cross-section is detected. 
Illuminating a droplet with a light beam of uniform intensity u results in an 
intensity deficit I which is proportional to the projected cross-sectional area 
  (D.1) 
The He-Ne laser used in our setup operates in the TEM00 mode, and exhibits a 
Gaussian beam intensity u(x, y) that is obtained as  
  (D.2) 
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where D is the curvature of the spherical wavefront and w is the beam radius. The plane, 
where the beam wavefront is planar ( ) is referred to as the beam waist and the 
beam radius is denoted as w0. At large distance from the waist the beam diverges linearly 
with distance, with a constant cone angle Ө. The Rayleigh range zR is defined as the 
distance from the waist to the point where the beam area has doubled. 
Because in our setup, at different distances from the laser beam expander the 
beam radius w is almost the same, so we assume that the laser beam is parallel. The 
curvature effect can be neglected and the plane wave approximation ( ) is used. 
The intensity profile can be expressed as follows: 
  (D.3) 
Placing an opaque sphere of radius R in the path of the parallel laser beam, the 
transmitted light power is given as follows: 
D®¥
D®¥
2 2 2 2 2( )/ /
0 0( ) ( , ) . .




  (D.4) 
  (D.5) 
 
A photodiode detects the transmitted intensity. If an aperture with radius a is used 
between the droplet and the photodiode. The shadow detected in the photodiode produced 
by a sphere of radius R becomes: 
  (D.6) 
where w is the laser beam radius. 
The photodiode output voltage is linearly proportional to the detected laser light 
intensity, which can be expressed in terms of an intensity ratio: 
  (D.7) 
  (D.8) 
where C is a constant, and   is the measured intensity of the laser beam 
(only with the aperture). I0  is the measured intensity of the unobstructed laser beam. If I0 
is constant and w >> R, equation (D.8) can be rewritten as the following: 
  (D.9) 
where C1 and C2 are constants to be determined from calibration. Equation (D.9) 
confirms that the output voltage of the photodiode is linear proportional to the area of the 
drop. 
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